Fortrea Holdings, FTRE and NASDAQ

Fortrea (NASDAQ:FTRE) Misses Q4 Revenue Estimates, Stock Drops
Clinical research company Fortrea Holdings (NASDAQ:FTRE) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 1.8% year on year to $697 million. The company’s full-year revenue guidance of $2.
Fortrea Holdings Inc. (NASDAQ:FTRE) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 3, 2025 Fortrea Holdings Inc. misses on earnings expectations. Reported EPS is $0.18 EPS, expectations were $0.36. Operator: Ladies and gentlemen, thank you for standing by,
Evercore ISI Sticks to Their Hold Rating for Fortrea Holdings Inc. (FTRE)
Evercore ISI analyst Elizabeth Anderson CFA maintained a Hold rating on Fortrea Holdings Inc. (FTRE – Research Report) yesterday and set a
What To Expect From Fortrea’s (FTRE) Q4 Earnings
Clinical research company Fortrea Holdings (NASDAQ:FTRE) will be reporting earnings tomorrow before market hours. Here’s what investors should know.
Fortrea Holdings Inc. (FTRE) Q4 Earnings and Revenues Miss Estimates
Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.18 per share, missing the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.19 per share a year ago. These figures are adjusted for non-recurring items.
Barclays Sticks to Its Hold Rating for Fortrea Holdings Inc. (FTRE)
In a report released today, Luke Sergott from Barclays maintained a Hold rating on Fortrea Holdings Inc. (FTRE – Research Report), with a price
Fortrea (NASDAQ:FTRE) Price Target Cut to $12.00 by Analysts at Barclays
Fortrea (NASDAQ:FTRE – Get Free Report) had its price objective lowered by investment analysts at Barclays from $25.00 to $12 ...
StockStory.org on MSN3d
Why Fortrea (FTRE) Shares Are Plunging Today
What Happened? Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) fell 18.5% in the pre-market session after ...
Fortrea price target lowered to $10 from $17 at BofA
BofA lowered the firm’s price target on Fortrea (FTRE) to $10 from $17 and keeps an Underperform rating on the shares after a Q4 miss and FY25 ...
Fortrea (NASDAQ:FTRE) Price Target Lowered to $11.00 at The Goldman Sachs Group
Fortrea (NASDAQ:FTRE – Get Free Report) had its target price decreased by analysts at The Goldman Sachs Group from $22.00 to ...
Multibillion-dollar public company shakes up board amid stock slump
A Durham company with a slumping stock is implementing changes to its board after reaching a deal with an activist investor.
Fortrea price target lowered to $12 from $25 at Baird
Baird lowered the firm’s price target on Fortrea (FTRE) to $12 from $25 and keeps a Neutral rating on the shares. The firm updated its model ...
Fortrea Shares at Record Low on Outlook for 2025 Revenue Decline
Shares of Fortrea Holdings sank to a new low after the company said it expects revenue to drop this year. The stock fell 31% to a new all-time low of $9.55 in the first half of the trading day. The ...
Fierce Biotech10d
Fortrea's Alaric Jackson Talks AI in Clinical Trials
In a recent interview with Fierce Biotech's Chris Hayden, Fortrea's Chief Technology and Data Officer Alaric Jackson ...
Seeking Alpha2d
Fortrea Holdings Inc. (FTRE) Q4 2024 Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to Fortrea Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being ...
Fortrea Reports Fourth Quarter and Full-Year 2024 Results; Issues Full-Year 2025 Guidance
For the three months and full-year ended December 31, 2024, from continuing operations:Revenues of $697.0 million for the fourth quarter, ...